MITQMoving iMage Technologies, Inc.
The schedule
- Thu15Oct
Over the next two quarters, announcements of large cinema modernization or esports venue projects could materially shift MITQ’s backlog and revenue visibility, with shares modeled at $0.55 ahead of any such news.
- Fri13Nov
- Sun29Nov
FQ2 2027 earnings will update investors on the sustainability of any new contracts and the trajectory of profitability heading into the seasonally important year-end period, with shares modeled at $0.65 before the release.
- Sun31Jan
Given persistent negative free cash flow and a small equity base, MITQ may pursue an equity or equity-linked financing over the next year to extend runway or fund growth, with the stock modeled at $0.53 ahead of any such transaction.
- Sun14Feb
- Sun28Feb
FQ3 2027 earnings will be critical for assessing MITQ’s path toward sustainable profitability following any capital raise or balance sheet actions, with shares modeled at $0.40.
Past
- Sat29Aug
FQ1 2027 earnings will show whether MITQ can sustain revenue growth and margin improvement after any listing-related overhang, with shares modeled at $0.45 going into the print.
- Sat15Aug
Actual outcome: Mixed · $0.57 at outcome
Shares remained largely flat, declining just 1.9%, as the company did not announce definitive corporate actions to resolve its minimum bid price deficiency. Without a clear resolution such as a reverse stock split or significant operational improvements to organically drive the share price above the $1 threshold, the stock traded sideways as investors awaited further clarity on listing compliance.
With shares trading under $1 (currently $0.70 in this pathway), MITQ faces ongoing risk of a minimum bid price deficiency notice on its exchange, forcing management to address listing compliance through operational improvement, corporate actions, or potential reverse split.
- Thu28May
Actual outcome: Bear · $0.55 at outcome
MITQ reported FQ4 2026 EPS of -$0.039, exactly meeting consensus estimates. Despite the in-line bottom line, the stock fell 10.8% over the following month as commentary on cinema and live-event demand failed to demonstrate the post-year-end momentum needed to reverse the stock's downward trend. Consequently, shares remained pressured near 52-week lows.
FQ4 2026 results and commentary on cinema and live-event demand will be the first look at post-year-end momentum, with the stock at $0.57 trading near 52-week lows and below its 50-day and 200-day moving averages.
